Aethon Therapeutics
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.
Aethon Therapeutics operates in biotechnology, health care, product research based in Greater New York Area, East Coast, Northeastern US, founded in 2022.
Within the biotechnology, health care, product research space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater New York Area, East Coast, Northeastern US.
It is recorded at the Series_A stage.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $30M.
| Sector | Biotechnology, Health Care, Product Research |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2022 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $30,000,000 |
Website: aethontx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account